NCT05178446 is a clinical trial in Morbid Obesity, sponsored by University of Foggia.

Who is sponsoring NCT05178446?

NCT05178446 is sponsored by University of Foggia.

What condition does NCT05178446 study?

NCT05178446 studies Morbid Obesity, GERD.

Is NCT05178446 still recruiting?

NCT05178446 is currently completed. Last updated 5 January 2022.

Last reviewed 2022-01-05 · How we verify

NCT05178446

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GERD After Sleeve Gastrectomy

Completed Last updated 5 January 2022

What this trial tests

trial in Morbid Obesity in 14,362 participants. Completed in 1 December 2021.

Timeline

1 January 2021

Primary endpoint
1 March 2021

1 December 2021

Quick facts

Lead sponsor	University of Foggia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	14,362
Start date	1 January 2021
Primary completion	1 March 2021
Estimated completion	1 December 2021
Sites	1 location across Italy

Conditions studied

Morbid Obesity — all drugs for Morbid Obesity →
GERD — all drugs for GERD →

Sponsor

University of Foggia

Who can join

Adults 18 to 60, any sex, with Morbid Obesity or GERD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure. This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA). Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The new onset of GERD after sleeve gastrectomy: A systematic review.
Pavone G, Tartaglia N, Porfido A, Panzera P, et al · · 2022 · cited 15× · PMID 35432994 · DOI 10.1016/j.amsu.2022.103584

Verify or expand the search:

Other recruiting trials for Morbid Obesity

Currently open trials in the same condition.

NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting

Other University of Foggia trials

Trials by the same sponsor.

NCT07513714 — ESTIM-UL: FES for Upper Limb Recovery After Stroke · NA · not yet recruiting
NCT07513753 — Focal Vibration Therapy in Post-stroke Shoulder Pain · NA · not yet recruiting
NCT07051499 — Effectiveness of TAP Block Versus Intravenous Analgesia in Postoperative Pain Management Following Gynecologic Laparosco · active not recruiting
NCT05766878 — The Rehabilitation of Atrophic Jaws Using Short Implants With Different Surface Characteristics · NA · completed
NCT07097090 — Improving Emotion Recognition Ability to Support Social Development in Children: A Quasi-Experimental Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05178446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Foggia
Last refreshed: 5 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05178446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing